title: Re: A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia.
authors.forename: Steven A
authors.initials: SA
authors.lastname: Kaplan